Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China (2020)#
Xu Yao, Zhiqiang Song, Wei Li, Yunsheng Liang, Yan Zhao, Hua Cao, Tao Chen, Chen Xue, Aiping Feng, Songmei Geng, Heng Gu, Shuping Guo, Yanling He, Yehong Kuang, Chunying Li, Xiaohong Li, Zhengxiao Li, Junqin Liang, Hongye Liu, Lingling Liu, Yumei Liu, Liu Zhi, Hai Long, Qianjin Lu, Yan Lü, Xiaoqun Luo, Xiaoyan Lv, Lin Ma, Zhu Shen, Xin Shi, Zhongxiang Shi, Xiangyang Su, Qing Sun, Jianping Tang, Aoxue Wang, Huiping Wang, Jianqin Wang, Mingyue Wang, Zaixing Wang, Yumin Xia, Ting Xiao, Zhiqiang Xie, Xing Huan, Ying Xiong, Zigang Xu, Bin Yang, Zhirong Yao, Jianbin Yu, Nan Yu, Kang Zeng, Jian-Zhong Zhang, Junling Zhang, Hua Zhao, Zuotao Zhao, Wei Zhu, Yinghua Zhu, Ying Zou
Abstract
Abstract Atopic dermatitis (AD) is a common disease clinically characterized by chronic recurrent eczematous lesions, dry skin, and pruritus. AD can negatively impact patients’ quality of life. The prevalence of AD in China has been increasing during the past few decades. Based on the most recent advances in the treatment of AD, we updated the 2014 version of the Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China regarding the definition, epidemiology, pathogenesis, clinical classification, diagnosis, prevention, and treatment of AD.